Clinical Trials Browser

Phase 3 × Multiple Myeloma × Magnetic Resonance Spectroscopy × Clear all

NCT03941860 2025-05-23

Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial

Phase 3 Completed

1 enrolled 1 chart

Multiple Myeloma

NCT01309334 2014-08-25

IMAJEM

Phase 3 Completed

Multiple Myeloma